Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.1B | 10.9B | 10.2B | 9.6B |
Cost of revenue | 6.7B | 7.1B | 6.3B | 5.3B |
Gross profit | 4.4B | 3.9B | 3.9B | 4.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.0B | 597M | 826M | 875M |
Operating income | 1.5B | 1.3B | 1.2B | 1.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 19M | 22M | 14M | 12M |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 1.8B | 1.6B | 1.8B |
Tax provision | 503M | 439M | 402M | 476M |
Net income | 1.4B | 1.3B | 1.2B | 1.4B |
Basic EPS | — | 149.4 | 130.2 | 154.3 |
Diluted EPS | — | 149.4 | 130.2 | 154.3 |
Basic average shares | — | 8.8M | 8.8M | 8.8M |
Diluted average shares | — | 8.8M | 8.8M | 8.8M |
EBITDA | 2.1B | 1.9B | 1.7B | 2.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |